EPO and leukemia: The direct effect of EPO on MPPs we described here could be one of the factors underlying the development of adverse side effects and comorbidities during long-term EPO use in the clinics and associations of high EPO levels with leukemias (Rainville et al., 2016; Ma et al., 2010; Halawi et al., 2017).